Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Durie, Brian G M, Dr Prof, Hoering, Antje, PhD, Abidi, Muneer H, MD, Rajkumar, S Vincent, Prof, Epstein, Joshua, Prof, Kahanic, Stephen P, MD, Thakuri, Mohan, MD, Reu, Frederic, MD, Reynolds, Christopher M, MD, Sexton, Rachael, MS, Orlowski, Robert Z, Prof, Barlogie, Bart, Prof, Dispenzieri, Angela, Prof
Published in The Lancet (British edition) (04.02.2017)
Published in The Lancet (British edition) (04.02.2017)
Get full text
Journal Article
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
Dispenzieri, Angela, Prof, Katzmann, Jerry A, PhD, Kyle, Robert A, Prof, Larson, Dirk R, MS, Melton, L Joseph, Prof, Colby, Colin L, Therneau, Terry M, Prof, Clark, Raynell, Kumar, Shaji K, MD, Bradwell, Arthur, Prof, Fonseca, Rafael, Prof, Jelinek, DF, Prof, Rajkumar, S Vincent, Prof
Published in The Lancet (British edition) (15.05.2010)
Published in The Lancet (British edition) (15.05.2010)
Get full text
Journal Article
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study
Kyle, Robert A, Larson, Dirk R, Therneau, Terry M, Dispenzieri, Angela, Melton, 3rd, L Joseph, Benson, Joanne T, Kumar, Shaji, Rajkumar, S Vincent
Published in The Lancet. Haematology (01.10.2014)
Published in The Lancet. Haematology (01.10.2014)
Get more information
Journal Article